In this article, the authors detail the seven pillars for successful management of tricuspid valve endocarditis. Surgical indications for tricuspid valve endocarditis include heart failure, uncontrolled infection, and septic emboli risk.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
valve
November 21, 2024
This cohort study, called the Real-World Observational Study for Investigating the Prevalence and Therapeutic Options for Atrial Functional Mitral Regurgitation (REVEAL-AFMR), aimed to investigate the prevalence, clinical characteristics, and outcomes of mitral valve (MV) surgery in atrial functional mitral regurgitation (AFMR).
October 3, 2024
Aortic stenosis affects more than 9 million people worldwide and is commonly treated with surgical aortic valve replacement (SAVR), which is known for producing excellent long-term outcomes. Recent advancements in transcatheter aortic valve replacement (TAVR) have shown noninferior or improved outcomes compared to SAVR across various risk levels.
September 5, 2024
The authors aimed to analyze the impact of preoperative septic cerebral embolism on early and late postoperative outcomes in patients with infective endocarditis (IE) undergoing valve surgery.
June 15, 2023
The authors performed a systematic review to determine whether direct oral anticoagulants (DOACs) are as safe and effective as vitamin K antagonists in the three months after bioprosthetic valve replacement.
February 12, 2023
The Society of Thoracic Surgeons published its newly developed short-term risk calculator of operative and thirty day risk specific to isolated mitral valve repair for primary mitral regurgitation and degenerative mitral etiology.
July 22, 2021
On July 22, The Annals of Thoracic Surgery published this consensus statement on nomenclature and classification of the congenital bicuspid aortic valve (BAV) and Its aortopathy.
June 4, 2021
On May 25, 2021, Dr. David Heimansohn successfully performed the first surgical implantation of biopolymer Tria™ heart valve in a patient with mitral valve disease at Ascension St. Vincent Hospital, Indianapolis, IN.
May 21, 2021
A large RCT concluding that 'surgical occlusion of the left atrial appendage provides additional protection against stroke when added to anticoagulation.' A number of limitations are briefly discussed. Findings are interesting in that absolute absence of surgical complications has been declared.
April 15, 2021
This study, conducted at the Cleveland Clinic, investigated reports of failure of the Trifecta externally wrapped, bovine pericardial aortic valve prosthesis (Abbott Laboratories, Abbott Park, IL). Concerns were raised about the long-term Trifecta durability.